Introduction
============

Fuchs corneal dystrophy (FCD; MIM 136800), first described by Ernst Fuchs in 1910 ([@b1-ijmm-37-06-1487]), is characterized by bilateral primary corneal guttae and a reduced endothelial cell density that can result in corneal edema, discomfort and blurred vision ([@b2-ijmm-37-06-1487]). The onset of FCD generally occurs in the 4th decade of life onwards, and FCD progresses at a slow rate over the next 2 to3 decades, causing severe impairment of endothelial cell function ([@b3-ijmm-37-06-1487],[@b4-ijmm-37-06-1487]), ultimately leading to severely impaired vision or blindness ([@b5-ijmm-37-06-1487],[@b6-ijmm-37-06-1487]). Currently, effective methods of restoring vision in advanced cases are corneal transplantation in the form of penetrating keratoplasty (PK) ([@b7-ijmm-37-06-1487]), Descemet\'s stripping endothelial keratoplasty (DSEK) ([@b8-ijmm-37-06-1487]) and Descemet\'s membrane endothelial keratoplasty (DMEK) ([@b9-ijmm-37-06-1487]).

FCD is genetically heterogeneous. To date, 4 loci, FCD1, FCD2, FCD3 and FCD4, on chromosomes 13, 18, 5 and 9, respectively, along with numerous linkage peaks and susceptibility loci, have been localized through linkage analysis. In addition, 4 causal FCD genes, namely collagen, type VIII, alpha 2 (*COL8A2*) (MIM 12052) ([@b4-ijmm-37-06-1487]), solute carrier family 4, sodium borate transporter, member 11 (*SLC4A11*) (MIM 610206) ([@b10-ijmm-37-06-1487],[@b11-ijmm-37-06-1487]), zinc finger E-box binding homeobox 1 (*ZEB1*) (MIM 189909) ([@b12-ijmm-37-06-1487]) and lipoxygenase homology domains 1 (*LOXHD1*) (MIM 613072) ([@b13-ijmm-37-06-1487]) have been identified, representing a small proportion of the total genetic load. Furthermore, a single nucleotide polymorphism (SNP) on chromosome 18q21, rs613872, in an intron of the transcription factor 4 (*TCF4*, MIM 602272) gene, which encodes a member of the E-protein family (E2-2), has been identified to be significantly associated with FCD; the association increased the probability of having FCD by a factor of 30 in individuals with 2 copies of the disease variants (homozygotes) and discriminated between case subjects and control subjects with approximately 76% accuracy ([@b14-ijmm-37-06-1487]). Another study that genotyped 18 SNPs within *TCF4* in Singaporean Chinese revealed that the minor allele of rs613872 was not present in the genotyped cohort; 2 SNPs (rs17089925 and rs17089887) located upstream and in intron 3 of *TCF4*, respectively, were significantly associated with FCD; another 3 SNPs (rs1348047, rs1452787 and rs2123392) also exhibited a marginal association with FCD ([@b15-ijmm-37-06-1487]). Another TGC trinucleotide repeat expansion (rs193922902) within intron 3 of *TCF4* has also been recently identified to be strongly associated with FCD, and a repeat length of \>50 was determined to play a pathogenic role in the majority of FCD cases and is considered to be a predictor of disease risk ([@b16-ijmm-37-06-1487]).

As the susceptibility of genes to mutations can vary in different ethnicities and in view of the limited information on the genetics of FCD in southwestern China, we undertook this study. We screened for mutations in 4 causal FCD genes (*SLC4A11*, *ZEB1*, *LOXHD1* and *COL8A2*) and genotyped 7 SNPs within the *TCF4* gene to determine whether these known causal genes are responsible for causing FCD in this specific multi-generational late-onset (LO) FCD Chinese pedigree.

Subjects and methods
====================

Case presentation
-----------------

The study protocol was approved by the Ethics Committee of the First People\'s Hospital of Yunnan Province and was in compliance with the Declaration of Helsinki. Written informed consent was obtained from all study participants or their guardians. Family members of this LO FCD Chinese family were recruited through a proband with FCD (a 46-year-old woman) who presented to the Department of Ophthalmology, the First People\'s Hospital of Yunnan Province; extended pedigrees were subsequently developed through interviews. The age of the affected pedigree members in generation II and III ranged from 36 to 67 years.

A total of 191 individuals of Chinese ethnicity, consisting of 104 females and 87 males who ranged in age from 58 to 89 years with an average age of 68.6 (SD 6.9 years), who had a normal cornea upon ophthalmic examination and no history of any ocular disease in their family were recruited as healthy controls.

Clinical evaluation
-------------------

All family members underwent a complete ophthalmic examination, including fundoscopy, a slit-lamp examination and specular microscopy, to document corneal guttae on December 2009. The diagnosis of FCD and the severity grading were based on a modified Krachmer scale, with grade 0 indicating an absence of guttae, grade 1 representing 12 or more central guttae, grade 5 denoting confluent central guttae with corneal edema, and grade 6 corresponding to disease severe enough to require keratoplasty ([@b3-ijmm-37-06-1487]). A detailed history was recorded for all subjects, including any family history and the duration of symptom onset.

DNA sample preparation
----------------------

After obtaining written informed consent, peripheral blood samples were collected from the proband and her family members. Genomic DNA was extracted from the leukocytes of the peripheral blood using a cell/tissue genomic DNA extraction kit (BioTeke Corp., Beijing, China) according to the manufacturer\'s instructions. In addition, genomic DNA from 191 healthy individuals was extracted and used as the control DNA.

Sequencing analysis of SLC4A11, ZEB1, LOXHD1, COL8A2, and TCF4
--------------------------------------------------------------

A total of 69 sets of primers ([Table I](#tI-ijmm-37-06-1487){ref-type="table"}) were designed to completely incorporate the exon and intron boundaries of the *SLC4A11* (NM_032034.3), *ZEB1* (NM_030751.5), *LOXHD1* (NM_144612.6) and *COL8A2* (NM_005202.3) genes, and all primers were designed such that they would be positioned on intronic segments at least 80 nucleotides on either side of the intron-exon boundary, to ensure complete reading of the exons. Primers were also designed to amplify the fragment of the *TCF4* gene containing 7 SNPs. Polymerase chain reaction (PCR) was carried out with 25 ng of genomic DNA as a template in a mixture of PCR buffer, 2.5 mM MgCl~2~, 0.2 mM of each dNTP, 0.4 *µ*M of each primer, and 0.75 units of rTaq DNA polymerase (Takara Bio, Dalian, China). After an initial denaturation step at 95°C for 5 min, 35 PCR cycles were performed as follows: 95°C for 30 sec, 60°C for 30 sec, and 72°C for 1 min, followed by a final extension at 72°C for 5 min. The PCR-amplified products were purified and sequenced on an ABI 3130 Genetic Analyzer using the BigDye Terminator Cycle Sequencing v3.1 kit (Applied Biosystems Life Technologies, Foster City, CA, USA) according to the manufacturer\'s instructions. Sequence assembly and analysis were performed using the DNASTAR Lasergene.v7.1 program (DNAstar Inc., Madison, WI, USA).

Strand-specific sequencing
--------------------------

To confirm the indels we observed as mixed sequences, the 2 alleles were cloned so they could be sequenced separately. Fragments containing insertion or deletion alleles were amplified as described above and sub-cloned within the pZeroBack/blunt vector by using ZeroBack Fast Ligation kit (Tiangen Biotech Co., Ltd., Beijing, China), according to the instructions provided by the manufacturer. Plasmid DNA was isolated using the MiniPrep kit (Qiagen China Co., Ltd., Shanghai, China), followed by bidirectional sequencing according to the method described above, with a pZeroBack/blunt forward primer, 5′-CGACTCACTATAGGGAGAGCGGC-3′ and reverse, 5′-AAGAACATCGATTTTCCATGGCAG-3′.

Short tandem repeat (STR) assay
-------------------------------

For TGC trinucleotide repeat expansion analysis of the *TCF4* gene, a 5′-FAM-conjugated forward primer corresponding to a location upstream of the STR region was used in PCR as previously described ([@b16-ijmm-37-06-1487]) ([Table I](#tI-ijmm-37-06-1487){ref-type="table"}). Following PCR, 2 *µ*l of DNA were mixed with 12 *µ*l of diluted Map Marker 1000 (BioVentures, Inc., Murfreesboro, TN, USA). The gene scan was carried out using an ABI 3130 Genetic Analyzer (Applied Biosystems Life Technologies).

Statistical analysis
--------------------

Statistical analysis was performed using the SPSS 16 software package. A χ^2^ test and Fisher\'s exact test were performed to compare the minor allele frequency (MAF) between data from the 1000 Genomes database and the Chinese healthy controls tested in the present study.

Results
=======

Findings on ocular examination
------------------------------

Microscopic investigation of the proband II-9, a 46-year-old woman, revealed the pleomorphism of corneal endothelial cells and the presence of corneal guttae in both eyes of the proband at her first presentation to our hospital on December 2009 ([Fig. 1](#f1-ijmm-37-06-1487){ref-type="fig"}). A 5-generation Chinese pedigree with 8 affected individuals was subsequently assembled through interviews with the initial proband ([Fig. 2](#f2-ijmm-37-06-1487){ref-type="fig"}, arrow). FCD was diagnosed using slit-lamp biomicroscopy and assigned severity grades as described in the Subjects and methods ([Fig. 2](#f2-ijmm-37-06-1487){ref-type="fig"}). The presence of an age-severity profile in this family was found to be generally consistent with that of LO FCD, which typically progresses from onset to end-stage disease over a period of approximately 2 decades ([@b17-ijmm-37-06-1487],[@b18-ijmm-37-06-1487]). Those affected in generation II, whose aged ranged from 56 to 67 years, all exhibited advanced advanced FCD (II-1, II-3, and II-5 all had grade 6 FCD; II-7 had grade 5 FCD), whereas in generations II and III, the affected individuals ranged in age from 36 to 46 years and typically had grades 3 and 4 disease (II-9 had grade 4 FCD; III-7, III-9, and III-19 all had grade 3 FCD) ([Fig. 2](#f2-ijmm-37-06-1487){ref-type="fig"}).

Genetic analysis
----------------

### Analysis of SLC4A11 gene

A total of 14 known variants (3 coding and 11 non-coding variants) from the Single Nucleotide Polymorphism Database (dbSNP) were detected in our analysis of the *SLC4A11* gene ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}). The 3 coding variants were synonymous variants that have been previously reported in Asian FCD cases and controls, namely, p.R161R (rs3827075, MAF: G=0.4798/2402), p.S213S (rs3803956, MAF: T=0.1663/833) ([@b19-ijmm-37-06-1487],[@b20-ijmm-37-06-1487]), and p.T833T (rs58757394, MAF: T=0.0901/450) ([@b20-ijmm-37-06-1487]) ([Fig. 3A](#f3-ijmm-37-06-1487){ref-type="fig"}). All 3 variants were detected in both the affected members of this FCD pedigree (p.R161R, 5/16; p.S213S, 2/16; and p.T833T, 5/16) and in 14 unaffected spouses who married into this family (the 14 spouses in whom DNA collection and genetic analysis were performed; p.R161R, 13/28; p.S213S, 5/28; and p.T833T, 6/28), as well as in unrelated, ethnically matched, healthy control subjects (n≥100) ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}).

Among the 11 non-coding variants identified in this FCD pedigree, 9 variants (rs3827076, rs3803958, rs6139040, rs3803955, rs3803954, rs3803953, rs3810561, rs10048856 and rs41281858) were detected in both the affected members of this FCD pedigree and in 14 unaffected individuals who married into this family. As for rs2144771, it was absent in the 8 affected members of this FCD pedigree (0/16), whereas it was detected in the 14 unaffected individuals who married into this family (16/28) ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}). For an intronic variant (rs372201212, MAF: G=0.0014/7), its minor allele (G) was detected in 4 of the 8 affected members of this FCD pedigree, II-1, II-5, III-9 and III-19 (4/16), and in 3 of 20 healthy descendants in this family (in whom DNA collection and genetic analysis were performed), III-3, IV-4 and IV-16 (3/40). This variant was absent in the other 4 affected members of this FCD pedigree (II-3, II-7, II-9 and III-7). As this variant was not identified in the 14 unaffected individuals who married into this family (0/28) ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}) ([Fig. 2](#f2-ijmm-37-06-1487){ref-type="fig"}), this variant was further tested in unrelated ethnically matched controls (n≥100), and the results revealed that it was also absent in the 191 healthy samples we tested (0/382) ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}).

### Analysis of ZEB1 gene

Bidirectional sequencing of the PCR product encompassing the 5′-UTR region and exon 1 of the *ZEB1* genomic DNA (GenBank reference ID: NC_000010.11) of the proband (II-9) of this pedigree revealed a homozygous 34 bp deletion involving 23 bp of the 5′-UTR region and the adjacent 11 bp at the 5′ end of exon 1 (GenBank reference ID: NM_030751.5): c.-86\_-53delins gggaggggtggaggcgg aggggtGGGGGGGAAGG (exon and 5′-UTR sequences are depicted by capital and lower case letters, respectively), as well as a heterozygous 7 bp indel in exon 1: c.-52\_-46delins GGGAGGG. Follow-up screening of the other family members of this specific FCD pedigree revealed that there was another 4 bp indel: c.-45\_-42delinsAGGG ([Fig. 4A](#f4-ijmm-37-06-1487){ref-type="fig"}). These 3 indels were named Indel 1, Indel 2 and Indel 3; however, these 3 indels were present in both the affected members of this FCD pedigree (Indel 1: Del, 16/16; Indel 2: Del, 9/16; and Indel 3: Del, 5/16) and in the 14 unaffected individuals who married into this family (Indel 1: Del, 28/28; Indel 2: Del, 14/28; Indel 3: Del, 12/28) ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}) ([Fig. 2](#f2-ijmm-37-06-1487){ref-type="fig"}), as well as in the unrelated, ethnically matched, healthy control subjects (Indel 1: Del, 368/370; Indel 2: Del, 183/370; Indel 3: Del, 162/370) ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}).

To further characterize the indels observed, 8 cases (II-1, II-3, II-5, II-7, II-9, III-7, III-9 and III-19), 3 healthy individuals who married into the family (II-4, II-6 and II-8), 2 healthy descendants of the family (III-11 and III-23) and 7 healthy control subjects (H4, H22, H31, H67, C8, C30 and C52) were enrolled in the validation set. PCR products of the segment encompassing the 5′-UTR region and exon 1 of the *ZEB1* gene were then subcloned into a pZeroBack/blunt vector. Plasmids were extracted from 10-20 positive colonies in each sample and sequenced bidirectionally by ABI 3130, according to the method described above. Subsequent sequence analysis demonstrated that 4 haplotypes (ordered as Indel 1/Indel 2/Indel 3), I/I/I, D/I/I, D/D/I and D/D/D, were detected in the present study ([Fig. 4B](#f4-ijmm-37-06-1487){ref-type="fig"}), and these observations were consistent with our bidirectional sequencing results. A schematic illustration of the *ZEB1* genomic DNA and the position of the 3 continuous indels (Indel 1, Indel 2 and Indel 3) relative to exon 1 is shown in [Fig. 4C](#f4-ijmm-37-06-1487){ref-type="fig"}. Although these 3 indels have not been previously reported in patients with FCD and are absent from dbSNP, they were detected in both the cases and healthy controls (n≥100) ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}) ([Fig. 2](#f2-ijmm-37-06-1487){ref-type="fig"}), leading to the conclusion that these 3 indels have no pathogenic correlation with FCD.

Another 2 known dbSNP intron variants were detected in our analysis of the *ZEB1* gene (rs220057, MAF: C=0.2524/1264 and rs220060, MAF: G=0.0787/394), both of them were detected in 14 healthy spouses who married into the family (rs220057, 2/28; rs220060, 1/28) ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}).

### Analysis of LOXHD1 gene

Only one known dbSNP intron variant was detected in our analysis of the *LOXHD1* gene (rs16939650, MAF: T=0.2584/1294), and it was detected in both the cases in this FCD pedigree (7/16) and in the 14 healthy spouses who married into the family (9/28) ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}). Another 2 intron variants were identified in the cases in this FCD pedigree that have not been previously reported in patients with FCD, namely, c.5332-126C\>T and c.1809+155G\>A (GenBank reference ID: NM_144612.6) ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}) ([Fig. 2](#f2-ijmm-37-06-1487){ref-type="fig"}). Both of these variants were absent from dbSNP and were not identified in the 14 unaffected spouses who married into this family (0/28) or in the 20 healthy descendants of this family (0/40) ([Table II](#tII-ijmm-37-06-1487){ref-type="table"} and [Fig. 2](#f2-ijmm-37-06-1487){ref-type="fig"}). Therefore, these 2 variants were further tested in unrelated, ethnically matched controls (n≥100), and the results revealed that both of the variants were also absent from the 191 healthy samples we tested (0/382) ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}). Heterozygous alterations in each variant were only identified in a single case each in this FCD pedigree (c.5332-126C\>T was found in II-3, and c.1809+155G\>A was found in II-5; [Fig. 2](#f2-ijmm-37-06-1487){ref-type="fig"}) and are likely examples of *de novo* mutations, the pathological consequences of which are uncertain.

### Analysis of COL8A2 gene

Five known dbSNP variants were detected in our analysis of the *COL8A2* gene, including 3 synonymous variants, p.A35A (rs57985157, MAF: T=0.0966/484), p.L335L (rs79833067, MAF: C= 0.0413/207) and p.G495G (rs35495320, MAF: T=0.1815/909), and 2 missense variants, p.R155Q (rs75864656, MAF: T=0.0377/188) and p.T502M (rs117860804, MAF: A=0.0587/294) ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}) ([Fig. 3](#f3-ijmm-37-06-1487){ref-type="fig"}). Four of these SNP coding variants from dbSNP (p.A35A, p.G495G, p.R155Q and p.T502M) have been reported in patients with FCD and unaffected individuals previously ([@b21-ijmm-37-06-1487]-[@b23-ijmm-37-06-1487]) and were present in both the affected members of this FCD pedigree (p.A35A, 5/16; p.G495G, 12/16; p.R155Q, 3/16; and p.T502M, 7/16) and in the 14 healthy spouses who married into the family (p.A35A, 12/28; p.G495G, 19/28; p.R155Q, 3/28; and p.T502M, 6/28) ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}) ([Fig. 2](#f2-ijmm-37-06-1487){ref-type="fig"}), as well as in the unrelated, ethnically matched, healthy control subjects (p.A35A, 128/364; p.G495G, 202/364; p.R155Q, 23/364; and p.T502M, 79/364) ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}).

In addition, the synonymous variant p.L335L, which has been previously reported in 2 patients with posterior polymorphous corneal dystrophy (PPCD; MIM 122000) ([@b18-ijmm-37-06-1487]), was present in 10 unaffected family members, 6 of whom were unrelated spouses who married into this family, and none of them displayed any clinical features of FCD ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}) ([Fig. 2](#f2-ijmm-37-06-1487){ref-type="fig"}). Furthermore, the finding of this synonymous variant in 182 healthy control individuals (p.L335L, 88/364) ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}), along with the absence of the p.L335L synonymous change in any of the 8 affected individuals in this Chinese FCD family ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}) ([Fig. 2](#f2-ijmm-37-06-1487){ref-type="fig"}) and the detection of this silent variant in 1 out of 116 healthy controls previously reported ([@b18-ijmm-37-06-1487]), leads to the conclusion that this substitution is a known polymorphism (dbSNP: rs79833067), and it has no association with FCD.

### TCF4 genotype

The PCR products of the *TCF4* gene, which contains 7 previously reported SNPs significantly associated with LO FCD, were sequenced. An analysis of an intronic SNP in the *TCF4* gene, rs613872 (MAF: G=0.0697/348), the risk allele (G) that has been identified to be significantly associated with FCD among Europeans through genome-wide association studies (GWAS) ([@b14-ijmm-37-06-1487]), revealed that the risk allele (G) was not present in any subject in our FCD pedigree (0/84; 84 refers to the total number of chromosomes detected for the 42 members of the pedigree in whom DNA collection and genetic analysis were performed), and only one individual was heterozygous for the risk allele (G) out of the 191 unrelated healthy controls we tested (1/382) ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}). This result was consistent with a previous study in which rs613872 was not present in Singaporean Chinese ([@b15-ijmm-37-06-1487]). The detection of 2 other SNPs (rs17089887, MAF: C=0.1689/846 and rs17089925, MAF: T=0.1569/786), which had been found to be significantly associated with FCD in Singaporean Chinese ([@b15-ijmm-37-06-1487]), revealed that only 3 out of 8 cases carried the heterozygous risk allele (C) of rs17089887 (3/16) and that only 1 out of 8 cases carried the heterozygous risk allele (T) of rs17089925 (1/16). Both of these risk alleles were also present in the 14 healthy individuals who married into this family (rs17089887: 6/28; rs17089925: 10/28) ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}). The analysis of another 3 SNPs that exhibited a marginal association with FCD in Singaporean Chinese (rs1348047, MAF: T=0.2780/1392; rs1452787, MAF: G=0.2708/1356; and rs2123392, MAF: C=0.3005/1504) ([@b15-ijmm-37-06-1487]) revealed that 7 out of 8 cases carried the risk allele (T) of rs1348047 (3 homozygous and 4 heterozygous for the risk allele, 10/16), 7 out of 8 cases carried the risk allele (G) of rs1452787 (1 homozygous and 6 heterozygous for the risk allele, 8/16), and all 8 cases carried the risk allele (C) of rs2123392 (5 homozygous and 3 heterozygous for the risk allele, 13/16). While these 3 risk alleles were also present in the 14 healthy individuals who married into this family (rs1348047, 16/28; rs1452787, 14/28; and rs2123392, 11/28) ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}), none of these 6 SNPs from dbSNP co-segregated with the disease.

One TGC trinucleotide repeat expansion (rs193922902) of TCF4, a repeat length \>50 of which is known to play a pathogenic role in the majority of FCD cases and is considered to be a predictor of disease risk ([@b16-ijmm-37-06-1487]), was also detected in the present study. The direct sequencing of the proband indicated that it contained one 11- and one 12-repeat allele ([Fig. 5A](#f5-ijmm-37-06-1487){ref-type="fig"}), and this result was further confirmed by STR analysis ([Fig. 5B](#f5-ijmm-37-06-1487){ref-type="fig"}). The expanded repeat was not found in any of the subjects in our pedigree (0/84) ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}), which indicated that this TGC trinucleotide expansion did not play a pathogenic role in this specific FCD family.

Discussion
==========

To date, progress toward identifying the underlying genetic components of FCD has been limited to the analysis of a few genes, including *SLC4A11*, *ZEB1*, *LOXHD1* and *COL8A2* ([@b4-ijmm-37-06-1487],[@b10-ijmm-37-06-1487],[@b12-ijmm-37-06-1487],[@b13-ijmm-37-06-1487],[@b20-ijmm-37-06-1487],[@b21-ijmm-37-06-1487]). Several genome-wide linkage studies have additionally provided evidence of linkage to several different chromosomal loci, namely FCD1, FCD2, FCD3 and FCD4, on chromosomes 13, 18, 5 and 9, respectively ([@b10-ijmm-37-06-1487],[@b24-ijmm-37-06-1487]-[@b26-ijmm-37-06-1487]), that appear to influence familial FCD. Thus, it appears that locus heterogeneity may exist for FCD, whereby mutations in several genes on different chromosomes may produce a common disease phenotype. Significant progress toward understanding non-familial FCD was made using GWAS. Baratz *et al* identified an SNP on chromosome 18q21, rs613872, in an intron of a gene encoding (*TCF4*) (MIM 602272) and showed a significant genome-wide association with FCD susceptibility in Europeans ([@b14-ijmm-37-06-1487]). This finding was further validated by Li *et al* ([@b27-ijmm-37-06-1487]) in another independent study. Although rs613872 was not found to be present in Singaporean Chinese FCD subjects, 2 other SNPs (rs17089887 and rs17089925) ([@b15-ijmm-37-06-1487]) and one TGC trinucleotide repeat expansion (rs193922902) ([@b16-ijmm-37-06-1487]) of the *TCF4* gene were reported to be significantly associated with FCD in the Chinese subjects.

Despite these insights, knowledge regarding the genetic basis of FCD in the China mainland population has remained limited, possibly due to the varying prevalence of FCD in different ethnic populations. The prevalence of FCD is generally considered to be approximately 4% in individuals above 40 years of age in the United States and accounts for the second most common indication for corneal transplants performed in the United States in patients over the age of 60 years ([@b28-ijmm-37-06-1487],[@b29-ijmm-37-06-1487]). The prevalence of FCD in other countries and areas has been confirmed by studies that have examined indications for PK at various institutions worldwide; prevalences of 15.4, 7.1 and 4.7% have been reported in populations from the UK ([@b30-ijmm-37-06-1487]), Singapore ([@b31-ijmm-37-06-1487]) and Australia ([@b32-ijmm-37-06-1487]), respectively, while studies in China suggest a relatively lower prevalence of FCD, namely, 4.5% in Taiwan ([@b33-ijmm-37-06-1487]) and \<3.9% in both the northern and eastern mainland of China ([@b34-ijmm-37-06-1487],[@b35-ijmm-37-06-1487]). Combined with clinical experience in the US that suggests a significantly decreased prevalence of FCD among individuals of African-American, Latin-American, or Asian origin, a greater understanding of the genetic basis of FCD in patients of different ethnic origins will shed more light on the molecular mechanisms of the disease.

To the best of our knowledge, the present study is the first study on a Chinese mainland population to focus on the genetic basis of the multi-generational Chinese pedigree with LO FCD that was previously reported by our group ([@b36-ijmm-37-06-1487]). In the present study, we performed a sequence analysis of the *SLC4A11*, *ZEB1*, *LOXHD1*, *COL8A2* and *TCF4* genes in this LO FCD pedigree.

Screening of the *SLC4A11* gene revealed 14 known dbSNP variants; among these, an intronic variant, is a known SNP from dbSNP (rs372201212, MAF: G=0.0014/7), its minor allele (G) was detected in 4 of 8 affected members of this FCD pedigree, II-1, II-5, III-9 (II-1\'s daughter), and III-19 (II-5′ son) (4/16), and 3 of 20 healthy descendants in this family, III-3 (II-1\'s son, III-9\'s older brother), IV-4 (II-1\'s granddaughter, III-3\'s daughter) and IV-16 (II-5\'s grandson, III-19\'s son) (3/40). Although this variant was not identified in any unaffected individuals who married into this family (0/28) or in the unrelated healthy controls (0/382), it may not be considered pathogenic as it did not co-segregate with the disease in this FCD pedigree. However, we cannot rule out the possibility that this variant has an association with FCD; if we consider the late onset of the disease and the fact that IV-4 and IV-16 were 20 and 14 years old, respectively, when the blood samples were collected in 2009, the disease status in these younger individuals is uncertain, as they may not have been old enough to manifest the disorder and may not clinically exhibit the disease, suggesting that this variant may be correlated with FCD in this family. Further analysis of this known SNP from dbSNP (rs372201212) in the *SLC4A11* gene in larger numbers of Chinese patients with FCD may elucidate the significance of this gene in corneal endothelial dystrophies.

Similarly, 2 intron variants of the *LOXHD1* gene were identified in this FCD pedigree: c.5332-126C\>T and c.1809+155G\>A (GenBank reference ID: NM_144612.6). These 2 variants have not been previously reported in FCD patients and were absent from dbSNP. Neither of these variants was identified in the unaffected family members or in the healthy controls (n≥100). As these variants were each found in only a single case in this FCD pedigree (c.5332-126C\>T in II-3, and c.1809+155G\>A in II-5), they are likely examples of *de novo* mutations.

*ZEB1* is a zinc finger E-box binding homeobox 1 gene (MIM 189909) and is also known as human zinc finger *TCF8*, which maps to chromosome 10p11.2, comprises 9 exons and encodes a transcription factor that is organized into multiple functional domains starting with N-terminal zinc finger clusters (172-292), followed by a homeodomain (581-640), a repression domain (754-901), C-terminal zinc finger clusters (905-981) and an acidic activation domain (1011-1124) ([@b37-ijmm-37-06-1487]). The structure of *ZEB1* allows for a wide range of functions as each zinc finger has different DNA-binding specificities and effects on gene expression ([@b38-ijmm-37-06-1487]). Mutations in the *ZEB1* transcripts have been shown to produce a wide range of ocular phenotypes ([@b39-ijmm-37-06-1487]). It was estimated that changes in this gene may account for approximately 50% of all PPCD cases ([@b40-ijmm-37-06-1487]), and its mutations also account for LO FCD ([@b12-ijmm-37-06-1487]). Through *ZEB1* screening, we identified 3 continuous indels located at the junction of the 5′-UTR and the adjacent 5′ end of exon 1 of the *ZEB1* gene in the cases in this FCD pedigree, and these 3 indels covered the region from -86 to -42 (numbering system based on the cDNA sequence with +1 corresponding to the A of the ATG TSS in the Ref Seq: NM_030751.5). A schematic illustration of the *ZEB1* genomic DNA and the location of these 3 continuous indels relative to exon 1 is shown in [Fig. 4C](#f4-ijmm-37-06-1487){ref-type="fig"}, and these 3 continuous indels, including 34 bp Indel 1 (containing 23 bp of the 5′-UTR region and 11 bp of the 5′ end of exon 1), 7 bp Indel 2 (containing 7 bp of exon 1), and 4 bp Indel 3 (containing 4 bp of exon 1). In addition, according to the UCSC Genome Browser (<http://genome.ucsc.edu/cgi-bin/hgGateway?hgsid=488683917_eMaJPXBAmxFX5D7tqTNSeva4dT39>), the bases affected by these 3 indels are relatively well conserved through evolution and also lie within transcription factor binding sites, and these regions are also enriched with H3K27AC, which is often found near active regulatory elements. In the case of Indel 1, the splice site variation affects the first splice site and may likely cause mis-splicing of the pre-mRNA transcript. This variation would lead to either exon skipping or intron retention, which would consequently result in an altered protein structure. Therefore, we hypothesized that a different haplotype of *ZEB1* will alter the mRNA structure or influence splicing efficiency. Further studies are needed to determine what effect, if any, these indels may have on *ZEB1* gene function and FCD pathogenesis; however, the presence of these 3 indels in the 14 healthy spouses who married into this family, the unaffected family members, and the healthy controls (n≥100) suggests that these 3 indels are not likely to be pathogenic.

In the screening of the *COL8A2* gene, neither of the previously reported pathogenic mutations of *COL8A2* (p.L450W and p.Q455K or Q455V) ([@b4-ijmm-37-06-1487],[@b21-ijmm-37-06-1487],[@b23-ijmm-37-06-1487]) was observed in this family, and none of the novel mutations were identified in the *COL8A2* gene in this LO FCD pedigree of Chinese descent. Our results are not surprising, as several studies have been published demonstrating a lack of *COL8A2* mutations in LO FCD ([@b22-ijmm-37-06-1487]).

Variations in candidate genes of FCD, deemed pathogenic on the basis of their absence in control chromosomes, were later identified as common polymorphisms in other ethnic populations ([@b21-ijmm-37-06-1487]-[@b23-ijmm-37-06-1487]), due to the fact that frequency of gene variant may depend greatly on the population screened. The MAF of 8 coding variants across *SLC4A11* (p.R161R, p.S213S and p.T833T) and *COL8A2* (p.A35A, p.R155Q, p.L335L, p.G495G and p.T502M) genes in healthy controls with Chinese ancestry (n≥100) were compared with MAF data from the 1000 Genomes database ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}). The statistical analysis demonstrated that 4 MAF of *COL8A2* gene (p.A35A, p.L335L, p.G495G and p.T502M) in Chinese healthy controls tested in the present study were all significantly higher than the data from 1000 Genomes (P\<0.01) ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}), indicated that these varations were rare in occidental populations ([@b21-ijmm-37-06-1487]), which may account for the absence of these minor allele distribution in control chromosomes in previous study ([@b21-ijmm-37-06-1487]-[@b23-ijmm-37-06-1487]).

Since the publication of the initial GWAS results indicating a significant association of an intronic SNP in *TCF4*, rs613872, with FCD ([@b14-ijmm-37-06-1487]), several studies across different cohorts from diverse populations have demonstrated that polymorphisms near *TCF4* were consistently linked to an increased prevalence of FCD ([@b15-ijmm-37-06-1487],[@b27-ijmm-37-06-1487]). These SNPs of *TCF4* were detected in this Chinese LO FCD pedigree, and the analysis revealed that the SNP rs613872, which is most highly associated with FCD in Caucasians, was not found to be present in this Chinese FCD family (0/84), and only one individual carrying the heterozygous variant of rs613872 was detected in the healthy controls (1/382), the MAF of healthy controls tested in the present study is significantly lower when compared with the data from 1000 Genomes (P\<0.01) ([Table II](#tII-ijmm-37-06-1487){ref-type="table"}). This result is consistent with previous research ([@b15-ijmm-37-06-1487]), in which rs613872 was not found to be present in Chinese FCD subjects, as well as with the data from the Human Genome Diversity Project, in which the minor (risk) allele, G, of rs613872 was found to be rare in populations from Africa, Eastern Asia, and Central and South America and more frequent in European, Middle Eastern, and Southern Asian populations ([@b41-ijmm-37-06-1487]). Two other SNPs (rs17089887 and rs17089925), which have been reported to be significantly associated with FCD in Singaporean Chinese ([@b15-ijmm-37-06-1487]), and a TGC trinucleotide repeat expansion (rs193922902) of *TCF4*, a repeat length \>50 of which plays a pathogenic role in the majority of FCD cases ([@b16-ijmm-37-06-1487]), were also detected in this Chinese LO FCD pedigree. The results revealed that none of these 3 SNPs co-segregated with the disease. Therefore, we investigated whether the three SNPs that were marginally associated with FCD in Singaporean Chinese (rs1348047, rs1452787 and rs2123392) ([@b15-ijmm-37-06-1487]) had some association with FCD in this Chinese LO FCD pedigree, and the results revealed that all three risk alleles were present in both the 8 cases and the 14 healthy individuals who married into this family. This finding led to the conclusion that none of these known SNPs provide strong evidence of pathogenesis in this specific muti-generational LO FCD Chinese family; however, because only seven fragments containing 7 SNPs were sequenced in the present study, we still cannot rule out the possibility that additional variants in other regions of the *TCF4* gene that were not assessed in the present study may be present that could confer phenotypic changes.

In conclusion, to identify and exclude known mutations and SNPs associated with FCD, we screened our LO FCD pedigree for all known exons and adjacent splice sites in the previously reported FCD genes that were associated with either LO FCD (*SLC4A11*, *ZEB1*, *LOXHD1* and *TCF4*) or EO FCD (*COL8A2*). Twenty-seven variants (including 22 known dbSNP vari ants and 5 variants absent from dbSNP) were detected. None of these variants provided strong evidence of pathogenesis, making it unlikely that SNPs or mutations in them caused FCD in this specific pedigree. The possibility of pathogenic changes occurring within the promoter, intronic, or untranslated non-coding regions of these genes playing a role in the pathogenesis of FCD has not been excluded in this study. The fact that we did not detect any pathogenic variants in these genes in our pedigree is likely a combination of the fact that these genes carry a low genetic load in FCD and that we screened only one LO FCD pedigree, a small sample that is underpowered for detecting variants that occur at relatively low frequencies. Clearly, a genome-wide linkage scan to identify linkage to one of the previously described FCD loci or to identify a novel locus for FCD will need to be performed in this multi-generational Chinese pedigree with LO FCD. Our observation, nevertheless, expands the current knowledge regarding the genetic status of Chinese ancestry patients with FCD.

The authors would like to thank all the family members and other people who generously participated in the study. The study was supported by the joint grands from the Yunnan Scientific and Technology Committee and Kunming Medical University, P.R. China (no. 2012FB090).

![Clinical features of proband with late-onset (LO) Fuchs corneal dystrophy (FCD). (A and B) A clinical image shows severe corneal guttae caused by FCD, with an associated loss of corneal clarity in both (A) right and (B) left eyes. (C and D) Slit-lamp image of the corneal guttae were observed in both the (C) right and (D) left eyes. (E and F) Specular microscopy of the both the (E) right and (F) left eyes revealed pleomorphism of the corneal endothelial cell and corneal guttae (proband was 46 years of age when the microscopic investigation performed in December 2009).](IJMM-37-06-1487-g00){#f1-ijmm-37-06-1487}

![Pedigree of a Chinese family with late-onset (LO) Fuchs corneal dystrophy (FCD) with genotypes of 11 variantions identified across the *SLC4A11*, *LOXHD1*, *ZEB1* and *COL8A2* genes. Squares, males; circles, females; diagonal lines, deceased; filled symbols, affected individuals; unfilled symbols, unaffected individuals or not known to be affected; arrowhead, the proband. The double cross symbol indicates individuals in whom DNA collection and genetic analysis were performed, age is presented in years (y) and a severity grade is indicated for affected and unaffected individuals examined in detail in December 2009. Genotypes of 11 variantions identified across the *SLC4A11*, *LOXHD1*, *ZEB1* and *COL8A2* genes are shown below the individual symbols in the following order: i) *SLC4A11*: c.777+10T\>C (rs372201212); ii) *LOXHD1*: c.5332-126C\>T and c.1809+155G\>A; iii) *ZEB1*: Indel1, Indel2 and Indel3; and iv) COL8A2: p.A35A, p.R155Q, p.L335L, p.G495G and p.T502M. Genotypes of 3 intronic variations (*SLC4A11*: c.777+10T\>C; and *LOXHD1*: c.5332-126C\>T and c.1809+155G\>A) and 3 synonymous variations of *COL8A2* (p.A35A, p.L335L and p.G495G) are shown in alleles. Three indels of *ZEB1* (Indel 1, Indel 2 and Indel 3) are showed as: D, deletion; I, insertion. Two missense variations of *COL8A2* (p.R155Q and p.T502M) are shown as: +, wild-type; M, missense mutation.](IJMM-37-06-1487-g01){#f2-ijmm-37-06-1487}

![Sequence electropherograms of 8 coding variants detected across the *SLC4A11* and *COL8A2* genes and 3 intronic variants detected in *SLC4A11* and *LOXHD1* genes. (A) Eight coding variants detected in *SLC4A11* and *COL8A2* genes. *SLC4A11*: c.481A\>C (p.R161R), c.639G\>A (p.S213S) and c.2499G\>A (p.T833T); and *COL8A2*: c.105G\>A (p.A35A), c.464G\>A (p.R155Q), c.1005C\>G (p.L335L), c.1485G\>A (p.G495G) and c.1505C\>T (p.T502M). Wide-type sequences are shown in the top panel for comparison. The underline marks the variated codon. (B) Three intron variants detected in *SLC4A11* and *LOXHD1* genes. *SLC4A11*: c.777+10T\>C (rs372201212); and *LOXHD1*: c.5332-126C\>T and c.1809+155G\>A (both absent from dbSNP). The underline marks the variant nucleotide.](IJMM-37-06-1487-g02){#f3-ijmm-37-06-1487}

###### 

Sequencing analysis of the *ZEB1* gene. (A) Sequence electropherograms of PCR products encompassing the 5′-UTR region and exon 1 of the *ZEB1* genomic DNA. Sequences and sequencing chromatograms of PCR products encompassing 5′-UTR region and exon 1 of the *ZEB1* genomic DNA from H4 (healthy control), II-9 (proband), II-3 (FCD case), and II-1 (FCD case) are shown from top to bottom (homozygous is shown in only one sequence, heterozygous is shown in both sequences). *ZEB1* genomic DNA sequence (GenBank reference ID: NC_000010.11) was show above (exon and 5′-UTR seqences are depicted by upper and lower case letters, respectively) The breakpoint is indicated by the red arrow. Three indels detected in the present study are indicated in different colors: green for Indel 1, 34 bp indel containing 23 bp of the 5′-UTR region and 11 bp 5′ end of exon 1 (NM_030751.5: c.-86\_-53delinsgggaggggtggaggcggaggggtGGGGGGGAAGG); red for Indel 2, 7 bp (NM_030751.5:c.-52\_-46delinsGGGAGGG); blue for Indel 3, 4 bp indel (NM_030751.5:c.-45\_-42delinsAGGG). Transcription start site (TSS) is indicated by a horizontal green arrow underneath ATG. The numbering system used for sequence variations is based on cDNA sequence with +1 corresponding to the A of the ATG TSS (GenBank Reference ID: NM_030751.5). FCD, Fuchs corneal dystrophy. Sequencing analysis of *ZEB1* gene. (B) DNA sequencing results of the four haplotypes subcloned into pZeroBack/blunt vector. Three indels were underlined in different colors: green for Indel 1; red for Indel 2; and blue for Indel 3. Sequencing chromatograms of 4 haplotypes (ordered as Indel 1/Indel 2/Indel 3), I/I/I, D/I/I, D/D/I, D/D/D, are shown from top to bottom. The 5′ and 3′ boundaries of indel are shown by a vertical red and a blue arrow, respectively. TSS is indicated by a horizontal green arrow underneath ATG. (C) Schematic illustration of the ZEB1 genomic DNA and distribution of 3 continuous Indels (Indel 1, 2 and 3) relative to exon 1. The numbering system used for sequence variations is based on cDNA sequence with +1 corresponding to the A of the ATG TSS (GenBank Reference ID: NM_030751.5). FCD, Fuchs corneal dystrophy.
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![Analysis of TGC trinucleotide repeat expansion (rs193922902) of *TCF4*.(A)Sanger DNA sequencing of DNA samples of proband showed heterozygous for allele (TGC)~11~ and (TGC)~12~. (B) STR analysis of PCR amplicons of proband verified heterozygous for allele (TGC)~11~ and (TGC)~12~.](IJMM-37-06-1487-g06){#f5-ijmm-37-06-1487}

###### 

Primer sequences used to amplify exons of the *SLC4A11*, *ZEB1*, *LOXHD1* and *COL8A2* genes, and 7 fragments containing 7 SNPs within the *TCF4* gene.

  Gene        Exon                                                  Forward primer (5′→3′)       Reverse primer (5′→3′)      Product size (bp)   Coding region size (bp)
  ----------- ----------------------------------------------------- ---------------------------- --------------------------- ------------------- ------------------------------------------------------
  *SLC4A11*   1                                                     GCCCGGTCCCTTCCTCTC           GCCAAAAGCATTCCAGCACTAG      553                 136
              2, 3                                                  CGGCTAGGGAATGCTGGAGA         GGAGCAGCGGGAGGATTCT         631                 153, 50
              4, 5                                                  CCCGCTGCTCCCCTCTTC           GCAGTGCTCCAGCCCTCTTC        720                 232, 82
              6                                                     GGCGGCCCAACCAACTT            CCGCGTGTTTGAATAGGGATAG      556                 124
              7, 8, 9A                                              GGGGAGAGCACCTTCACCTG         CCCCGTCTGTGTTCTCGTCA        688                 219, 94, 126
              9B, 10, 11                                            TCCCCAGCAAACCCTCTCTC         TGGGGCAGCAATATGGTGG         687                 114, 133
              12                                                    TGCGCTTTATGCCTTTTTCAA        CACGGGCACACACTCAGCTT        493                 74
              12, 14, 15A                                           CCCCCTGGAGCCCTTTCT           GGCGGCCACCAAGTTCTG          755                 253, 107, 169
              15B, 16, 17A                                          TCCGGGAAATCGAGAGTGAGT        AGCGCGATGTAGAGGAAGAGG       791                 174, 196
              17B, 18                                               GCCGTGGACCCTGAGGAGT          CCCGCCCATTCTCCACAC          617                 170
              19                                                    TGGGCTGGGATGGGTGTC           GGCAGTAGCAGGGACACAGGT       537                 70
  *ZEB1*      1                                                     CCGCCCGGTCCCTAGCAACAAG       CGGAGGGGGGCAGAGAGCACTACTT   413                 58
              2                                                     TTGCTGTTAAAATCCTGGCTCTG      TCCTTCCACTCAGCCATACTTTG     1,115               20
              3                                                     TCCTTTTCAGATTTCGGGAAGTT      TGATTCTCGTTTGCTGTGACATG     789                 60
              4                                                     GGGGCTGTCTATTGTCCAACTTT      AAGGCAGATTCAGGAAAACCACT     994                 162
              5                                                     AGCCCGTATTTGAACCCTGACT       TTCCATTGAGGGCTGAGTTGTC      512                 203
              6                                                     CAAAACAACCATCAGGCTCACA       TTCACTCCCTCTCATTGCCTCTA     674                 106
              7A                                                    CAGTTCTGTCACAAGCATGCATG      TGGCTAGGCTGCTCAAGACTGT      791                 1,811[a](#tfn1-ijmm-37-06-1487){ref-type="table-fn"}
              7B                                                    CCCATTACAGGCAACCAGTTCT       TGGGGTTCATTTGCATTTGC        876                 
              7C                                                    TGAAAAGATGCAAGCTGGACAG       GGCTGGATCACTTTCAAGGGT       702                 
              7D                                                    GGCCATTGCTGACCAGAACA         GGTTCACAGCCACACTTCCTCAT     743                 
              8                                                     TTCGGTGTCCTTGCTTTCTTTC       GCCGAGATTGAGATTGCGTG        640                 181
              9                                                     AACCCTCCCCTTTCTACAACATG      GGCACACCCGGATTTATTTTG       900                 593
  *LOXHD1*    1                                                     AGAAGGCAGAGGGAACA            ATGGGATAATCAGTGAGGAA        439                 130
              2                                                     GTTGTGCTGGAAAGATTAC          CTGGTCCCTGGTGAGA            844                 115
              3                                                     TTCCTCCTCCATCCAC             CAATCCCTCACTTTCATC          508                 81
              4                                                     ACCGAGGTTCAGGAGA             GCAAGACAGGCACGA             405                 185
              5                                                     GGGGTAAGTGTAGATGGTG          TTCTTGCTTTCCCTGTG           650                 99
              6                                                     AAGGAAGTCTGTAGGCTGAA         CTGGCTTAGGTAGAAGAGTGG       657                 149
              7                                                     AAGGTAATCGCCAGTCA            TTCAGGAGCAGGAGGA            473                 124
              8                                                     ATTCTTAGCCAACCCG             GGATAATCATAACCACCAA         822                 251
              9, 10                                                 TGGGTGATACCTACTTTG           ATCCCTTCCTCCTTTC            1,116               136, 161
              11, 12                                                GTTTATTGCTTGGAGGAT           ACTTGGAGATGGCTTTT           1,127               87, 136
              13                                                    GGAAGGTCAGCCCAGAT            TCCCAGGAGTCCAACAG           546                 155
              14                                                    GAGCAGGATGTTGTGG             AGTAGGGCTGGGTCTT            913                 161
              15                                                    TCCAATCTCAGCCAAAC            GCACAGGCAGGAACTCT           452                 77
              16                                                    ATTTACACGCTTTCCTG            TCTTAGTCCTCCCTTCTC          857                 197
              17                                                    CCCCTCTTGTTTCTCAC            CATTGGGTCCTCAGTTT           677                 193
              18                                                    GCTGGTATGTGACTCCTC           GATTTGCCTGGTATGG            737                 161
              19, 20                                                CTGGCTCTTTGTTGGG             TGTTTGTTCCTGTGGGT           1,423               463, 155
              21                                                    TCCAGCAAACCTATCTTC           GTCTTCTTCCAGGACTACC         513                 134
              22                                                    CAGGCAAATGACTAATGG           GAGGGAAGGAAGATGGA           428                 164
              23                                                    GGGCTCACAGATACAGG            GACCCAACACTAAACACC          640                 105
              24, 25                                                AACTCACCCATGTAACCA           CAGGGATGAAAGACCAA           1,441               129, 165
              26                                                    GGGATACGGAGAAGAGTG           AGGAGGAGCAGGGTGAG           897                 182
              27, 28                                                GGCAAGACAGGAGCAT             GGACGAGGATAAACCAG           1,984               117, 163
              29                                                    TGGCAGGTAGATTTAGTGA          AGGGCAAGGGCAGA              661                 155
              30, 31                                                GAGTGGGTTGAGTGGG             ATCGGTGATGGTGGG             608                 210, 136
              32                                                    GAAACCTACCCAACAATG           GTGGCTCACCCAAAGT            1,003               209
              33                                                    GCCTGGACTTAGGTTGG            GAAGAAATGTTATGGGTAGA        657                 128
              34                                                    GCAGCATTACCTTCTATTT          AAGCCAGAGGAACCAG            786                 118
              35                                                    GCAAATGTCAGCGTTCT            GTTGGAGTGGTAAGGGA           601                 175
              36                                                    AACTTCCCTGCTTCCT             AACACTGGCTCTTTCATAC         743                 186
              37                                                    CTCTGAGACCACCTAACC           ACAAGCCTCTTCCAATC           879                 171
              38                                                    CTACCTACAACGCCTCAA           TGGGCATCCGAACAG             620                 133
              39                                                    AAATGCTTACCTGCTTCA           TCTGGTCCCTACTCTGC           646                 159
              40                                                    CCAAGTAGCAGGAGGG             TTGCCACTGGGTTTATT           1,449               699
  *COL8A2*    1                                                     CCCCGCGACTTTGAAAATTG         GGGCGCCTGAGGATCTGAT         470                 193
              2A                                                    CCCATTCTTCCTCTCCCGTGTA       TTGCCTAAGCCAGCTGGACC        630                 1,919[a](#tfn1-ijmm-37-06-1487){ref-type="table-fn"}
              2B                                                    GGCCTCAAGGGGGATAATGG         TTTCCCAGCCAGGCCACTAG        606                 
              2C                                                    GGGCTTCCTGGCAGACGTG          CGGTGTGGCATGGGCAGA          627                 
              2D                                                    TGGGGCCTTCGATGAGACTG         GCCGCCTCTGTTCAGCTTTT        624                 
  *TCF4*      Including rs613872                                    CCCAGGCACTCCCCATTTACT        GGACGTTGAACAGCTTGACAGG      579                 
              Including rs17089925                                  TTCCTGCTTCTGACCC             AGTGACCTGCTTGCTC            924                 
              Including rs17089887                                  GCATAGAAGGCAAGA              GTAAGGAAGAGGCAAT            972                 
              Including rs1348047                                   GGGAATCATAAGCACG             GGCGAAAGGTAGCG              576                 
              Including rs1452787                                   GAATGGGAATCAAATAG            GCAAACTGTGGGAGG             760                 
              Including rs2123392                                   AAGAATGTCAGGGAAAG            CAGAATCACTGCGAAA            960                 
              Including rs193922902 (TGC repeat)                    CAGATGAGTTTGGTGTAAGATG       ACAAGCAGAAAGGGGGCTGCAA      230+(TGC)12-100     
              5-FAM-TCF-Fuchs, including rs193922902 (TGC repeat)   FAM-CAGATGAGTTTGGTGTAAGATG   ACAAGCAGAAAGGGGGCTGCAA                          

Exons were amplified as multiple fragments because of their large size. SNPs, single nucleotide polymorphisms.

###### 

Sequence variants identified across the *SLC4A11*, *ZEB1*, *LOXHD1* and *COL8A2* genes, and genotypes of 7 SNPs within the *TCF4* gene in 8 cases of this FCD pedigree, 14 unrelated spouses married into the family, and ethnically matched healthy controls (n≥100).

  Gene        Chr position           rs ID         mRNA                                                 Amino acid change   Functional consequence   MAF                                                                            
  ----------- ---------------------- ------------- ---------------------------------------------------- ------------------- ------------------------ --------------- --------------------------------------------- ---------------- ---------------------
  *SLC4A11*                                        NM_032034.3                                          NP_114423.1                                                  n=16                                          n=28             n≥100
                                                                                                                                                                                                                                    
              20:3237709             rs3827076     c.-30G\>C                                                                nc                       G=0.4503/2255   5/16 (0.3125)                                 6/28 (0.2143)    
              20:3235025             rs3803958     c.137-131A\>G                                                            nc                       C=0.0038/19     1/16 (0.0625)                                 3/28 (0.1071)    
              20:3234400             rs6139040     c.340-86G\>C                                                             nc                       G=0.1697/849    1/16 (0.0625)                                 5/28 (0.1786)    
              20:3234173             rs3827075     c.481A\>C                                            p.R161R             syn                      G=0.4798/2402   5/16 (0.3125)                                 13/28 (0.4643)   108/280 (0.3857)^a^
              20:3233935             rs3803956     c.639G\>A                                            p.S213S             syn                      T=0.1663/833    2/16 (0.1250)                                 5/28 (0.1786)    45/274 (0.1642)
              20:3233504             rs372201212   c.777+10T\> C                                                            nc                       G=0.0014/7      4/16 (0.2500)                                 0/28 (0.0000)    0/382 (0.0000)
              20:3233480             rs3803955     c.777+34G\>A                                                             nc                       T=0.2498/1250   9/16 (0.5625)                                 11/28 (0.3929)   
              20:3233374             rs2144771     c.777+140C\>A                                                            nc                       G=0.4477/2242   0/16 (0.0000)                                 16/28 (0.5714)   
              20:3231077             rs3803954     c.1091-19T\>C                                                            nc                       G=0.0669/335    3/16 (0.1875)                                 9/28 (0.3214)    
              20:3231073             rs3803953     c.1091-15A\>C                                                            nc                       G=0.4006/2005   2/16 (0.1250)                                 6/28 (0.2143)    
              20:3230418             rs3810561     c.1463+97T\>G                                                            nc                       A=0.2117/1059   5/16 (0.3125)                                 12/28 (0.4286)   
              20:3228711             rs10048856    c.2241-4G\>A                                                             nc                       T=0.1160/580    8/16 (0.5000)                                 6/28 (0.2143)    
              20:3228437             rs41281858    c.2437-9C\>T                                                             nc                       A=0.1591/796    5/16 (0.3125)                                 4/28 (0.1429)    
              20:3228366             rs58757394    c.2499G\>A                                           p.T833T             syn                      T=0.0901/450    5/16 (0.3125)                                 6/28 (0.2143)    18/264 (0.0682)
                                                                                                                                                                                                                                    
  *ZEB1*                                           NM_030751.5                                                                                                                                                                      
                                                                                                                                                                                                                                    
              10:31319149            NA            c.-86\_-53delinsgggaggggtggaggcggaggggtGGGGGGGAAGG                       utr 5 prime, ex          NA              Del=16/16 (1.0000)                            28/28 (1.0000)   368/370 (0.9946)
              10:31319183            NA            c.-52\_-46delinsGGGAGGG                                                  ex                       NA              Del=9/16 (0.5625)                             14/28 (0.5000)   183/370 (0.4946)
              10:31319190            NA            c.-45\_-42delinsAGGG                                                     ex                       NA              Del=5/16 (0.3125)                             12/28 (0.4286)   162/370 (0.4378)
              10:31502731            rs220057      c.481+222C\>T                                                            in                       C=0.2524/1264   0/16 (0.0000)                                 2/28 (0.0714)    
              10:31504588            rs220060      c.685-15G\>A                                                             in                       G=0.0787/394    0/16 (0.0000)                                 1/28 (0.0357)    
                                                                                                                                                                                                                                    
  *LOXHD1*                                         NM_144612.6                                                                                                                                                                      
                                                                                                                                                                                                                                    
              18:46507838            NA            c.5332-126C\>T                                                           in                       NA              T=1/16 (0.0625)                               0/28 (0.0000)    0/382 (0.0000)
              18:46579407            rs16939650    c.1809+223G\>A                                                           in                       T=0.2584/1294   7/16 (0.4375)                                 9/28 (0.3214)    
              18:46579475            NA            c.1809+155G\>A                                                           in                       NA              A=1/16 (0.0625)                               0/28 (0.0000)    0/382 (0.0000)
                                                                                                                                                                                                                                    
  *COL8A2*                                         NM_005202.3                                          NP_005193.1                                                                                                                 
                                                                                                                                                                                                                                    
              1:36100138             rs57985157    c.105G\>A                                            p.A35A              in, syn                  T=0.0966/484    5/16 (0.3125)                                 12/28 (0.4286)   128/364 (0.3516)^a^
              1:36099217             rs75864656    c.464G\>A                                            p.R155Q             mis                      T=0.0377/188    3/16 (0.1875)                                 3/28 (0.1071)    23/364 (0.0632)
              1:36098676             rs79833067    c.1005C\>G                                           p.L335L             syn                      C=0.0413/207    0/16 (0.0000)                                 6/28 (0.2143)    88/364 (0.2418)^a^
              1:36098196             rs35495320    c.1485G\>A                                           p.G495G             syn                      T=0.1815/909    12/16 (0.7500)                                19/28 (0.6786)   202/364 (0.5549)^a^
              1:36098176             rs117860804   c.1505C\>T                                           p.T502M             mis                      A=0.0587/294    7/16 (0.4375)                                 6/28 (0.2143)    79/364 (0.2170)^a^
                                                                                                                                                                                                                                    
  *TCF4*                                           NM_003199.2                                                                                                       n=16                                          n=28             n≥100
                                                                                                                                                                                                                                    
              18:55382827            rs1348047     c.369+20627C\>A                                                          in                       T=0.2780/1392   10/16 (0.6250)                                16/28 (0.5714)   
              18:55539976            rs1452787     c.145+45304t\>c                                                          in                       G=0.2708/1356   8/16 (0.5000)                                 14/28 (0.5000)   
              18:55541025            rs17089887    c.l45+44255A\>G                                                          in                       C=0.1689/846    3/16 (0.1875)                                 6/28 (0.2143)    
              18:55543071            rs613872      c.145+42209c\>a                                                          in                       G=0.0697/348    0/16 (0.0000)                                 0/28 (0.0000)    1/382 (0.0026)^a^
              18:55547634            rs2123392     c.145+37646a\>g                                                          in                       C=0.3005/1504   13/16 (0.8125)                                11/28 (0.3929)   
              18:55586156:55586227   rsl93922902   c.72+818_73-804CTG(10_37)                                                STR                      NA              TGC~([@b11-ijmm-37-06-1487])~=8/16 (0.5000)   9/28 (0.3214)    
              18:55733603            rs17089925    NA                                                                       in                       T=0.1569/786    1/16 (0.0625)                                 10/28 (0.3571)   

There were 8 cases and 14 unrelated spouses (in whom DNA collection and genetic analysis were performed); thus, there were 16 and 28 chromosomes, respectively. As we did not obtain good sequencing results for all the 191 controls, the total number of samples for each gene analysis differed, n≥100). MAF, minor allele frequency; NA, not available; in, intron variant; ex, exon variant; utr, untranslated regions variant; nc, non-coding transcript variant; syn, synonymous codon; mis, missense; STR, short tandem repeat. Lower case superscript letters indicates statistical significance (aP\<0.01) when comparing the MAF data from the 1000 Genomes database with that from the Chinese ancestry healthy controls tested in the present study.
